drugset / Trial / NCT04720963
Intranasal Remimazolam for Premedication in Pediatric Patient
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Anesthetic inhalation induction could be one of the most stressful experiences for children during the perioperative period, with almost 50% of them showing anxiety. It is an essential challenge for pediatric anesthesiologists on how to decrease anxiety for children in the operating room (OR) environment and to facilitate a smooth induction of anesthesia. Various factors like parental separation, unfamiliar surroundings, fear of physicians and needle injections can increase their preoperative anxiety. The researchers conducted the current study to investigate whether intranasal remimazolam can reduce anxiety in children before surgery.
Timeline
- Start
- 2021-02-07
- Primary completion
- 2022-02-28
- Completion
- 2022-02-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Dexmedetomidine | Other / unclassified | 2 ug/kg | Intranasal |
| Subject | Remimazolam | Small molecule | 1.5 mg/kg | Intranasal |